CClinicalTrials.gg
CompletedNCT05239572SUNI-SEAUpdated Oct 30, 2023

Scaling Up NCD Interventions in South East Asia

An interventional study of screening, prevention and counselling in Diabetes Mellitus, Type 2, Hypertension and Cardiovascular Diseases, sponsored by University Medical Center Groningen. Completed at 1 site in Vietnam. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-30.

Sponsored by University Medical Center Groningen · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
16,850
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Study summary

The SUNI-SEA study is an intervention study that measures effectiveness and cost-effectiveness of prevention and early diagnosis of diabetes and cardiovascular diseases in communities and primary healthcare (PHC) facilities in Indonesia, Myanmar and Vietnam.

Read the detailed description

The study takes place in Vietnam and Indonesia in Intergenerational Self-Help Clubs (ISHGs), where community members assemble for activities concerning social, economical improvement and health and well-being. Volunteers in these ISHGs are trained in performing screening for diabetes and cardiovascular diseases and counselling participants concerning healthy living, or referral to primary healthcare facilities, if needed. At PHC level further diagnosis and if needed treatment is provided and referral back to ISHGs is done for lifestyle interventions.

In Indonesia screening takes place in the Posbindu programme, where trained volunteers (cadres) screen and counsel participants. If needed referral to Puskesmas (primary healthcare facilities is done, where further diagnosis and treatment takes place. Activities for health promotion and lifestyle interventions take place under supervision of the Posbindu programme.

In Myanmar and Indonesia individual monitoring and health education of participants is done through mobile applications.

Measuring of uptake, follow-up and adherence to interventions is done through routine data collection, through surveys, and through semi-structured interviews and focus group discussions.

02

Conditions studied

  • Diabetes Mellitus, Type 2
  • Hypertension
  • Cardiovascular Diseases

Keywords

  • prevention
  • early diagnosis
  • lifestyle intervention
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's enrollment of 16,850 is above the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

University Medical Center Groningen is the lead sponsor of 609 studies on the registry; 174 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • All adults living in geographical area where research takes place

Exclusion criteria

Exclusion Criteria:

  • Persons who are not able to come to location of screening, due to illness or other chronic condition causing immobility.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16,850 participants (actual)

Study arms

  • Experimental
    Screening and early detection of diabetes and cardiovascular diseases

    Screening for NCDs based on questionnaire concerning vital information, lifestyle, simple measures of length, bodyweight, BMI, blood pressure, application of FinRisk score and WHO risk score. Health promotion and lifestyle counselling and referral to PHC facilities for further diagnosis and treatment.

    Combination Product: screening, prevention and counselling

Interventions

  • Combination productscreening, prevention and counselling

    Screening in Intergenerational solidarity clubs in Myanmar and Vietnam and in Posbindu programme in Indonesia

    Also known as: lifestyle coaching for persons with risk factors for NCDs, referral to primary healthcare facilities for further diagnosis and treatment, simple treatment of NCDs at primary healthcare level, Online monitoring and counselling for risk factors for NCDs

06

What researchers measure

Primary outcomes

  1. Uptake of NCD screening offered in communities

    Number of adults eligible for NCD screening in communities who participate in screening

    Time frame: 18 months from offering screening options in communities until measuring uptake

  2. Adherence to follow-up advice

    Percentage of participants in screening who follow up on recommendations given during screening (referral, lifestyle change)

    Time frame: 12 months from counselling and advice to individual until measuring adherence to follow-up that has been recommended

  3. Uptake of health education (health promotion, awareness of risk factors)

    Percentage of adults above 21 years in communities participating in one or more health education sessions offered

    Time frame: 12 year between first health education session and measuring uptake (based on participants' lists)

Secondary outcomes

  1. Unit costs of screening, prevention and early diagnosis of NCDs per Quality Adjusted Life Year gained

    Unit costs of NCD screening, prevention, early diagnosis intervention per Quality Adjusted Life Year gained

    Time frame: 18 months between starting calculation of costs of interventions and assessment of final assessment of benefits

  2. Cost-effectiveness of NCD interventions

    Comparison of costs and effects between intervention and business as usual, using diff in diff method

    Time frame: 18 months between baseline survey and endline survey

Other outcomes

  1. Impact of training of community health volunteers in NCD interventions on knowledge attitudes and practices of volunteers

    Difference in knowledge, attitudes and practices (KAP) of volunteers in ISHCs in Myanmar and Vietnam, and cadres in Posbindu in Indonesia as result of training offered in the research project, measured by pre- and post-training KAP survey and six months after training.

    Time frame: 6 months between provision of training to community health volunteers and measuring their skills, knowledge and attitudes

  2. Impact of training of community health volunteers on their performance in NCD interventions.

    Performance of community health volunteers six months after training, measured by observational study, with measuring adherence to standard operating procedures for screening for NCDs and health education.

    Time frame: 6 months between provision of training to community health volunteers and measuring their performance

07

Study locations

1 site
  • Health Strategy and Policy Institute
    Hanoi, Vietnam
08

References and documents

Individual participant data

Plan to share: Yes — Following open research guidelines of European Union data will be shared about screening, follow-up and referral. Data collected in cos-effectiveness analysis will be shared

Supporting information: Study protocol, Sap, Icf, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05239572
Lead sponsor
University Medical Center Groningen
Collaborators
University of Groningen, University of Passau, Universitas Sebelas Maret, Health Strategy and Policy Institute, Trnavska Universita v Trnava, HelpAge International, Thai Nguyễn University of Medicine and Pharmacy
Responsible party
Sponsor
First posted
Feb 15, 2022
Start date
Mar 31, 2022
Primary completion
Jun 30, 2023
Completion
Jun 30, 2023
Last update
Oct 30, 2023

Study contacts

Maarten Postma, PhD
principal investigator · University Medical Center Groningen
Robert Lensink, PhD
principal investigator · University of Groningen
Ari Probandari, PhD
principal investigator · University Sebelas Maret
Giang Nguyen Hoang, MPH
principal investigator · Health Strategy and Policy Institute
Anil Kumar Indira Krishna, PhD
principal investigator · HelpAge International
Michael Grimm, PhD
principal investigator · University of Passau

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion